Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Including Immunotherapies

View buyer

Estimated value

£32.0m

Awarded value

Awarded 15 Mar 2019

Suppliers

1

Lots

1

1 awarded

Published

05 Apr 2019

Deadline 18 Oct 2018

Description

Delivery of an Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Inc. Immunotherapies Homecare service from a GPhC registered Pharmacy. This will involve dispensing and delivering a range of medicines, with the option required to deliver Ancillaries, remove waste product, provide suitable fridge, nursing administration of medicines. Membership of the EMPC may vary throughout the life of the contract. Access to this contract may vary upon membership. Other UK and/or other participating NHS bodies (whether acting individually, or on behalf of, or together as members of any consortia) may become EMPC members during the life of any resulting contract. This tender is to establish a framework agreement for the supply of an Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Inc. Immunotherapies Homecare service to participating trusts, in line with the agreed specification. East Midlands Pharmacy Collaboration (EMPC) is a procurement collaborative hosted by Royal Derby Hospitals, NHS Foundation Trust, acting as an agent on behalf of its Member Organisations. The member organisations working with EMPC and who may purchase under any contract awarded through this process can be found at http://www.derbyhospitals.nhs.uk/primary/pharmacy/empc/ .

Scope

Reference
D85.D22
Total value
£32,000,000 excluding VAT
Commercial tool
Standalone contract
Contract dates
01 Feb 2019 to 31 Jan 2023
CPV classifications
33000000 85140000
Particular suitability
Small and medium-sized enterprises (SME)

Submission & procedure

Submission deadline
18 Oct 2018, 11:00 pm

Award details

Awarded supplier(s), contract period and value as published in the award notice.

Awarded value

Award date

15 Mar 2019

Contract start

01 Feb 2019

Contract end

31 Jan 2023